EEG-Guided Cognitive Function Preservation in Patients With Brain Tumors
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: EEG-Based Neural Signal Decoding Strategy.
- Who it may be relevant to
- Registry conditions: Glioma, Brain Neoplasm, Brain Tumor Adult. Basic parameters: 18 years — 75 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Prospective Single-Arm Study of EEG-Based Neural Signal Decoding for Cognitive Function Preservation in Patients Undergoing Brain Tumor Surgery
Overview
Brain tumors and their surgical treatment may impair cognitive function, affecting patients' quality of life. This prospective single-arm study aims to evaluate the feasibility and clinical utility of an EEG-based neural signal decoding strategy for cognitive function preservation in patients undergoing brain tumor surgery. Participants will undergo standardized neuropsychological assessments together with preoperative, intraoperative, and postoperative electrophysiological recordings. The study will investigate whether EEG-based neural decoding can improve objective cognitive function assessment and support individualized functional preservation during brain tumor surgery.
Detailed description
This is a prospective, single-center, single-arm interventional study designed to investigate an EEG-based neural signal decoding strategy for higher-order cognitive function preservation in patients undergoing brain tumor surgery.
Eligible patients with brain tumors scheduled for surgical treatment will be enrolled. Participants will receive standardized neuropsychological assessments before and after surgery. High-density EEG recordings will be acquired during different stages of the perioperative period, including task-based and resting-state paradigms when applicable. Neural signal decoding methods will be used to extract cognitive-related electrophysiological features and evaluate their association with postoperative cognitive outcomes.
The primary objective is to evaluate the feasibility of EEG-based neural signal decoding for objective cognitive assessment and functional preservation during brain tumor surgery. Secondary objectives include exploring the relationship between electrophysiological biomarkers and neuropsychological performance, evaluating perioperative cognitive changes, and providing preliminary evidence for individualized cognitive protection strategies in brain tumor patients.
Interventions
- Procedure EEG-Based Neural Signal Decoding Strategy
EEG-based neural signal decoding will be performed during the perioperative period to identify cognitive functional networks and assist individualized cognitive function preservation during brain tumor surgery.
Primary outcome measures
- Mini-Mental State Examination (MMSE) Total Score [Time frame: Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months]
- Montreal Cognitive Assessment (MoCA) Total Score [Time frame: Baseline, postoperative 1 week, postoperative 1 month, and postoperative 3 months]
Eligibility criteria
Inclusion criteria
- Age 18 years to 75 years.
- Patients diagnosed with brain glioma and scheduled for surgical treatment.
- Conscious and able to understand study procedures.
- Able to complete neuropsychological assessments.
- Willing to participate and provide written informed consent.
Exclusion criteria
- Severe dysfunction of major organs (heart, lung, liver, or kidney).
- Severe psychiatric disorders or cognitive impairment.
- Severe language impairment preventing completion of study procedures.
- Any other condition judged by the investigator to make participation inappropriate.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
China · 1 center
- Tianjin Huanhu Hospital — Tianjin
Identifiers
NCT: NCT07699172 · 2026-BRAIN-TUMOR-COG-01